May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Dye–Enhanced Photocoagulation (DEP) for Treatment of Choroidal Neovascularization in Age Related Macular Degeneration. A phase II Study
Author Affiliations & Notes
  • G. Staurenghi
    Department of Clinical Science Luigi Sacco, Eye Clinic Luigi Sacco Hospital, University of Milano, Italy
  • G. Levi
    Department of Clinical Science Luigi Sacco, Eye Clinic Luigi Sacco Hospital, University of Milano, Italy
  • P. Danzi
    Department of Ophthalmological Science, Eye Clinic Spedali Civili, University of Brescia, Italy
  • C. Veronese
    Department of Ophthalmological Science, Eye Clinic Spedali Civili, University of Brescia, Italy
  • R. Flower
    New York University, New York, NY
    Univerity of Maryland, Baltimore, MD
  • Footnotes
    Commercial Relationships  G. Staurenghi, Novadaq, R; G. Levi, None; P. Danzi, None; C. Veronese, Novadaq, R; R. Flower, Novadaq, C.
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 2150. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      G. Staurenghi, G. Levi, P. Danzi, C. Veronese, R. Flower; Dye–Enhanced Photocoagulation (DEP) for Treatment of Choroidal Neovascularization in Age Related Macular Degeneration. A phase II Study . Invest. Ophthalmol. Vis. Sci. 2006;47(13):2150.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : A phase II study was planned to compare efficacy of choroidal neovascular membrane (CNV) feeder vessel treatment (FVT) preformed by application of 810 nm laser energy during indocyanine green (ICG) dye transit through the feeder vessels (i.e., DEP) to application of the laser energy alone.

Methods: : A fundus camera was modified for ICG angiography by replacing its xenon flash lamp with an 810 nm wavelength diode laser. Live ICG images were acquired by a CCD video camera and displayed on a LCD monitor located above the patient's eye. The output fiber optic of an 810 nm laser photocoagulator was mounted on a joystick–controlled micromanipulator in the fundus camera's optical system for positioning the photocoagulator laser beam on the fundus while viewing live ICG video images of the choroidal vasculature. The device makes possible precise delivery of photocoagulation energy to CNV FVs upon arrival of a secondarily–injected, high–concentration ICG dye bolus in a targeted FV. Patients with minimally classic or other choroidal lesions were randomized to ICG–DEP FVT or FVT alone.

Results: : 40 patients randomized (20 FVT / 20 ICG–DEP FVT). Data at 12 months showed only 1 case treated with FVT with choroidal hemorrhage (2.5 %). Closure of choroidal neovascular membrane was achieved in 87,5% and maintained after 12 months in 71.4% in ICG–DEP arm and 64.2% and 55.5% respectively in FVT arm. The number of laser burns to achieve the closure with DEP FVT were less than FVT (3 to 9 vs. 100 to 300). Four patients droped out or changed type of treatment (1 ICG–DEP and 3 FVT). Mean treatments for each case was 3,88 (1 to 7).

Conclusions: : Preliminary data analysis suggests that feeder vessels are identifiable and treatable during the dye transit. ICG–DEP appears to be a safe procedure. It also facilitate FVT by reducing the number of burns necessary for vessel closure and makes the treatment of larger diameter new vessels possible.

Keywords: laser • choroid: neovascularization 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×